Literature DB >> 10802082

Cost-effectiveness of IVF in women 38 years and older.

C Suchartwatnachai1, A Wongkularb, C Srisombut, W Choktanasiri, S Chinsomboon, A Rojanasakul.   

Abstract

OBJECTIVE: To compare the cost per delivery in women younger than 38 years with women equal to or older than 38 years of age attempting IVF.
METHODS: All couples undergoing IVF treatment between October 1991 and September 1998 were enrolled in this study. A standard protocol of controlled ovarian hyperstimulation was employed throughout the study. Four hundred and seven cases were allocated to two groups - group I composed of patients younger than 38 years of age and group II of patient equal to or older than 38 years of age. The total cost of each successful outcome was the goal of our study.
RESULTS: A total of 407 women underwent 722 stimulated cycles for IVF of which 122 cycles (16.89%) did not proceed to oocyte retrieval. We found statistically significant differences in the cancellation rate, the number of hMG ampoules, the number of oocytes retrieved, the number of oocytes fertilized, the number of embryos transferred, the clinical pregnancy rate, the rate of multiple pregnancy, the delivery per initiated cycle and the cost per delivery between the two groups (P<0.05, significant). The cost per delivery in group II was approximately 3.6 times that of group I.
CONCLUSIONS: Women age 38 years or more have less chance of a successful outcome from IVF treatment. Couples contemplating IVF should be provided with accurate information about prognosis for the pregnancy and the financial costs.

Entities:  

Mesh:

Year:  2000        PMID: 10802082     DOI: 10.1016/s0020-7292(99)00215-5

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  6 in total

Review 1.  Public financing of IVF: a review of policy rationales.

Authors:  Philipa Mladovsky; Corinna Sorenson
Journal:  Health Care Anal       Date:  2009-04-03

2.  Setting the stage for novel public policy and fiscal impact studies regarding the economics of in vitro fertilisation: An introduction.

Authors:  David J Walsh; Anthony P H Walsh
Journal:  J Exp Clin Assist Reprod       Date:  2010-01-15

3.  The combined effect of age and basal follicle-stimulating hormone on the cost of a live birth at assisted reproductive technology.

Authors:  Melinda B Henne; Barbara J Stegmann; Adrienne B Neithardt; William H Catherino; Alicia Y Armstrong; Tzu-Cheg Kao; James H Segars
Journal:  Fertil Steril       Date:  2007-07-31       Impact factor: 7.329

4.  Female ageing and reproductive outcome in assisted reproduction cycles.

Authors:  T Y Tan; S K Lau; S F Loh; H H Tan
Journal:  Singapore Med J       Date:  2014-06       Impact factor: 1.858

5.  What should we focus on before preimplantation genetic diagnosis/screening?

Authors:  Zhong Zheng; Xiaoming Zhao; Bing Xu; Ning Yao
Journal:  Arch Med Sci       Date:  2018-01-16       Impact factor: 3.318

Review 6.  Use of in vitro fertilization-ethical issues.

Authors:  Kjell Asplund
Journal:  Ups J Med Sci       Date:  2019-11-05       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.